Amfitas 50mg Injection

Amfitas 50mg Injection is an antifungal medication. It is used in the treatment of severe fungal infections and kala-azar. It kills the infection causing fungi and thus, treats the infection.

Amfitas 50mg Injection is administered as an injection by a healthcare professional. Kindly do not self administer. Before you take this medicine, inform your doctor if you suffer from diabetes, liver/kidney problems or are on dialysis or have low potassium level in blood.

It may lead to a few common side effects like headache, vomiting, nausea, stomach cramps and fever. You may also notice some injection site reactions like pain, swelling or redness. Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive or breastfeeding.

• Severe fungal infections
• Kala-azar

Severe fungal infections
Amfitas 50mg Injection works by killing the fungi which can cause serious infections. It is given by a doctor or nurse and should not be self-administered. It usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all the fungi and yeast causing the infection are killed and do not become resistant.

Kala-azar
Kala azar is a disease caused by leishmania parasites mainly by the bite of infected sandflies. Amfitas 50mg Injection helps to kill the infection causing parasites and helps to treat the infection. This medicine is given by a doctor or nurse and should not be self-administered. It usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all the parasites are killed and do not become resistant.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Mycoflu-E

• Injection site reactions (pain, swelling, redness)
• Nausea
• Vomiting
• Chills
• Headache
• Anemia (low number of red blood cells)
• Decreased potassium level in blood
• Abnormal liver function tests
• Decreased magnesium level in blood
• Diarrhea
• Decreased appetite
• Hypotension (low blood pressure)
• Skin rash
• Nephrocalcinosis
• Increased creatinine level in blood
• Abnormal renal function tests
• Renal tubular acidosis

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Amfitas 50mg Injection is an antifungal medication. It kills fungi by destroying the fungal cell membrane.

• It is usually given as an injection over 1-2 hours under the supervision of a medical professional.

• Amfitas 50mg Injection can cause rash, chills, headache, and tiredness during initial days of the treatment, but these may fade away with time.

• Your doctor may ask you for regular blood tests to monitor your blood sugar, potassium, magnesium and kidney function.

• Inform your doctor immediately if you notice pain or blood upon urination, swelling of the face and trouble breathing.

• Inform your doctor if you are pregnant, planning pregnancy or breastfeeding.

Phillips MA, Stanley SL Jr. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1424.

Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 1571-75.

Sheppard D, Lampiris HW. Antifungal Agents. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 836-38.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 68-69.

Medsacpe. Amphotericin. [Accessed 29 Mar. 2019] (online) Available from:

Amphotericin B. San Dimas, California: Gilead Sciences, Inc.; 2000. [Accessed 04 Feb. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. Jornal de Pediatria. 2004; 80(5):4-6. [Accessed 29 Mar. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 29 Mar. 2019] (online) Available from: